
This review summarizes recent progress in the development of myostatin zzso for the treatment of muscle wasting zzso It also focuses on findings in myostatin biology that may have implications for the development of zzso zzso 

There has been progress in evaluating zzso therapies in animal models of muscle wasting zzso Some programs have progressed into clinical development with initial results showing positive impact on muscle zzso normal mice myostatin zzso results in enlarged muscles with increased total force but decreased specific force zzso zzso zzso An increase in zzso protein synthesis without zzso satellite cell proliferation and fusion leads to muscle zzso with unchanged zzso zzso A specific force reduction is not observed when zzso muscle, the zzso therapeutic target of myostatin inhibitor therapy, is made zzso has been shown to be expressed by a number of tumor cell lines in mice and zzso 

zzso zzso remains a promising therapeutic strategy for a range of muscle wasting zzso 

